📣 We’re hiring!
IrsiCaixa is looking for a predoc researcher to pursue a PhD in a research environment focused on infectious diseases and immunity.
🔵 More info & application: https://f.mtr.cool/4rpprx99jd
IrsiCaixa is looking for a predoc researcher to pursue a PhD in a research environment focused on infectious diseases and immunity.
🔵 More info & application: https://f.mtr.cool/4rpprx99jd
October 2, 2026 at 9:02 AM
📣 We’re hiring!
IrsiCaixa is looking for a predoc researcher to pursue a PhD in a research environment focused on infectious diseases and immunity.
🔵 More info & application: https://f.mtr.cool/4rpprx99jd
IrsiCaixa is looking for a predoc researcher to pursue a PhD in a research environment focused on infectious diseases and immunity.
🔵 More info & application: https://f.mtr.cool/4rpprx99jd
🏥 #CampusCanRuti, home to IrsiCaixa, shines as a key hub, with 20+ professionals in the world’s most cited researchers ranking.
😍 Bonaventura Clotet, Javier Martínez-Picado, and @rutgerwalls.bsky.social from IrsiCaixa are recognized for their 2023 impact. Congrats!
www.irsicaixa.es/en/can-ruti-...
😍 Bonaventura Clotet, Javier Martínez-Picado, and @rutgerwalls.bsky.social from IrsiCaixa are recognized for their 2023 impact. Congrats!
www.irsicaixa.es/en/can-ruti-...
November 26, 2024 at 3:08 PM
🏥 #CampusCanRuti, home to IrsiCaixa, shines as a key hub, with 20+ professionals in the world’s most cited researchers ranking.
😍 Bonaventura Clotet, Javier Martínez-Picado, and @rutgerwalls.bsky.social from IrsiCaixa are recognized for their 2023 impact. Congrats!
www.irsicaixa.es/en/can-ruti-...
😍 Bonaventura Clotet, Javier Martínez-Picado, and @rutgerwalls.bsky.social from IrsiCaixa are recognized for their 2023 impact. Congrats!
www.irsicaixa.es/en/can-ruti-...
Dans cette étude #CovidLongPediatrique, l’analyse de différents marqueurs « a montré que la molécule CCR6 s'exprime de manière "clairement différente" chez les enfants avec ou sans la maladie, la plaçant comme un marqueur biologique possible ».
Un estudio describe las alteraciones inmunitarias específicas en...
Un estudio liderado por IrsiCaixa ha descrito por primera vez en profundidad las alteraciones...
www.infosalus.com
April 9, 2026 at 11:20 AM
Dans cette étude #CovidLongPediatrique, l’analyse de différents marqueurs « a montré que la molécule CCR6 s'exprime de manière "clairement différente" chez les enfants avec ou sans la maladie, la plaçant comme un marqueur biologique possible ».
🐀 @who.int leads a study on Andes hantavirus across 21 countries with scientific coordination from IrsiCaixa.
🌎 The initiative investigates viral transmission, clinical evolution and immune response, strengthening preparedness for health emergencies.
👉🏽 www.irsicaixa.es/en/irsicaixa...
🌎 The initiative investigates viral transmission, clinical evolution and immune response, strengthening preparedness for health emergencies.
👉🏽 www.irsicaixa.es/en/irsicaixa...
June 15, 2026 at 1:16 PM
🐀 @who.int leads a study on Andes hantavirus across 21 countries with scientific coordination from IrsiCaixa.
🌎 The initiative investigates viral transmission, clinical evolution and immune response, strengthening preparedness for health emergencies.
👉🏽 www.irsicaixa.es/en/irsicaixa...
🌎 The initiative investigates viral transmission, clinical evolution and immune response, strengthening preparedness for health emergencies.
👉🏽 www.irsicaixa.es/en/irsicaixa...
🩸 New @naturecomms.bsky.social study with #IrsiCaixa collaboration explores therapeutic plasma exchange for #LongCovid, assessing its safety and efficacy in a phase II trial.
🧪 The study provides valuable insights into this complex condition.
👇🏽👇🏽👇🏽
www.nature.com/articles/s41...
🧪 The study provides valuable insights into this complex condition.
👇🏽👇🏽👇🏽
www.nature.com/articles/s41...
www.nature.com
March 11, 2025 at 8:40 AM
🩸 New @naturecomms.bsky.social study with #IrsiCaixa collaboration explores therapeutic plasma exchange for #LongCovid, assessing its safety and efficacy in a phase II trial.
🧪 The study provides valuable insights into this complex condition.
👇🏽👇🏽👇🏽
www.nature.com/articles/s41...
🧪 The study provides valuable insights into this complex condition.
👇🏽👇🏽👇🏽
www.nature.com/articles/s41...
💉 New results published in @naturecomms.bsky.social about the therapeutic vaccine against HIV designed at #IrsiCaixa.
🏥 A phase II clinical trial confirms that the immune response after receiving the vaccine improves HIV control without treatment.
👉 www.irsicaixa.es/en/phase-ii-...
🏥 A phase II clinical trial confirms that the immune response after receiving the vaccine improves HIV control without treatment.
👉 www.irsicaixa.es/en/phase-ii-...
March 7, 2025 at 9:20 AM
💉 New results published in @naturecomms.bsky.social about the therapeutic vaccine against HIV designed at #IrsiCaixa.
🏥 A phase II clinical trial confirms that the immune response after receiving the vaccine improves HIV control without treatment.
👉 www.irsicaixa.es/en/phase-ii-...
🏥 A phase II clinical trial confirms that the immune response after receiving the vaccine improves HIV control without treatment.
👉 www.irsicaixa.es/en/phase-ii-...
🔴 Today, on #WorldAIDSDay, we share hopeful data:
People who started antiretroviral treatment after 2⃣0⃣0⃣7⃣ have a #HIV reservoir up to 4⃣ times smaller.
💥 Learn more in a recent study led by #IrsiCaixa.
👉🏽 irsicaixa.es/en/viral-res...
People who started antiretroviral treatment after 2⃣0⃣0⃣7⃣ have a #HIV reservoir up to 4⃣ times smaller.
💥 Learn more in a recent study led by #IrsiCaixa.
👉🏽 irsicaixa.es/en/viral-res...
December 1, 2024 at 10:21 AM
🔴 Today, on #WorldAIDSDay, we share hopeful data:
People who started antiretroviral treatment after 2⃣0⃣0⃣7⃣ have a #HIV reservoir up to 4⃣ times smaller.
💥 Learn more in a recent study led by #IrsiCaixa.
👉🏽 irsicaixa.es/en/viral-res...
People who started antiretroviral treatment after 2⃣0⃣0⃣7⃣ have a #HIV reservoir up to 4⃣ times smaller.
💥 Learn more in a recent study led by #IrsiCaixa.
👉🏽 irsicaixa.es/en/viral-res...
🧒🦠 What drives #LongCOVID in children?
Our new @IrsiCaixa research in JCI Insight reveals:
🔹 Immune dysregulation
🔹 Reduced neutralizing antibodies
🔹 CCR6 as a potential biomarker (79% accuracy)
👉 A key step toward better diagnosis & treatments
🔗 doi.org/10.1172/jci....
#Pediatrics #Immunology
Our new @IrsiCaixa research in JCI Insight reveals:
🔹 Immune dysregulation
🔹 Reduced neutralizing antibodies
🔹 CCR6 as a potential biomarker (79% accuracy)
👉 A key step toward better diagnosis & treatments
🔗 doi.org/10.1172/jci....
#Pediatrics #Immunology
April 8, 2026 at 8:09 PM
🧒🦠 What drives #LongCOVID in children?
Our new @IrsiCaixa research in JCI Insight reveals:
🔹 Immune dysregulation
🔹 Reduced neutralizing antibodies
🔹 CCR6 as a potential biomarker (79% accuracy)
👉 A key step toward better diagnosis & treatments
🔗 doi.org/10.1172/jci....
#Pediatrics #Immunology
Our new @IrsiCaixa research in JCI Insight reveals:
🔹 Immune dysregulation
🔹 Reduced neutralizing antibodies
🔹 CCR6 as a potential biomarker (79% accuracy)
👉 A key step toward better diagnosis & treatments
🔗 doi.org/10.1172/jci....
#Pediatrics #Immunology
🇪🇺 Meet the team behind @lwnvivat.bsky.social, an EU-funded project coordinated by #IrsiCaixa!
Today, we’re introducing Júlia Albó, a predoctoral researcher at IrsiCaixa and a key member of the project, working on #WestNileVirus research.
🎥 Watch the video to learn more about her career!
👇🏽👇🏽👇🏽
Today, we’re introducing Júlia Albó, a predoctoral researcher at IrsiCaixa and a key member of the project, working on #WestNileVirus research.
🎥 Watch the video to learn more about her career!
👇🏽👇🏽👇🏽
Júlia Albó is a PhD student at @irsicaixa.es and part of our project. Watch the video below to learn about her research 👇
#WestNileVirus #VirusLikeParticle #EmergingDisease
#WestNileVirus #VirusLikeParticle #EmergingDisease
March 3, 2026 at 8:18 AM
🇪🇺 Meet the team behind @lwnvivat.bsky.social, an EU-funded project coordinated by #IrsiCaixa!
Today, we’re introducing Júlia Albó, a predoctoral researcher at IrsiCaixa and a key member of the project, working on #WestNileVirus research.
🎥 Watch the video to learn more about her career!
👇🏽👇🏽👇🏽
Today, we’re introducing Júlia Albó, a predoctoral researcher at IrsiCaixa and a key member of the project, working on #WestNileVirus research.
🎥 Watch the video to learn more about her career!
👇🏽👇🏽👇🏽
🪢 Avui, #DiaMundialSida, #IrsiCaixa i Fundació "la Caixa" presentem 🟥 RED, un documental que recull testimonis reals i la mirada de la recerca per entendre millor el #VIH entre record, estigma i futur.
🎬 A partir d'avui, RED, gratis, a CaixaForum+.
👉🏽 www.irsicaixa.es/ca/caixaforu...
🎬 A partir d'avui, RED, gratis, a CaixaForum+.
👉🏽 www.irsicaixa.es/ca/caixaforu...
December 1, 2025 at 7:58 AM
🪢 Avui, #DiaMundialSida, #IrsiCaixa i Fundació "la Caixa" presentem 🟥 RED, un documental que recull testimonis reals i la mirada de la recerca per entendre millor el #VIH entre record, estigma i futur.
🎬 A partir d'avui, RED, gratis, a CaixaForum+.
👉🏽 www.irsicaixa.es/ca/caixaforu...
🎬 A partir d'avui, RED, gratis, a CaixaForum+.
👉🏽 www.irsicaixa.es/ca/caixaforu...
🇭🇺 Science takes us to Budapest!
👩🏽🔬 We are at #EACR2026, one of Europe's leading congresses for cancer research.
👥 IrsiCaixa researchers are ready to learn, share and connect with the international cancer research community!
@helloeacr.bsky.social
👩🏽🔬 We are at #EACR2026, one of Europe's leading congresses for cancer research.
👥 IrsiCaixa researchers are ready to learn, share and connect with the international cancer research community!
@helloeacr.bsky.social
June 10, 2026 at 10:17 AM
🇭🇺 Science takes us to Budapest!
👩🏽🔬 We are at #EACR2026, one of Europe's leading congresses for cancer research.
👥 IrsiCaixa researchers are ready to learn, share and connect with the international cancer research community!
@helloeacr.bsky.social
👩🏽🔬 We are at #EACR2026, one of Europe's leading congresses for cancer research.
👥 IrsiCaixa researchers are ready to learn, share and connect with the international cancer research community!
@helloeacr.bsky.social
🚧 ¿Y si quitar los “frenos” del sistema inmunitario ayudara a combatir el #VIH?
🔬 En #IrsiCaixa demostramos, en el laboratorio, que combinar una #vacuna terapéutica con un #tratamiento anti PD-1 incrementa las células capaces de eliminar el VIH.
👉🏽 www.irsicaixa.es/es/el-efecto...
🔬 En #IrsiCaixa demostramos, en el laboratorio, que combinar una #vacuna terapéutica con un #tratamiento anti PD-1 incrementa las células capaces de eliminar el VIH.
👉🏽 www.irsicaixa.es/es/el-efecto...
January 13, 2026 at 11:10 AM
🚧 ¿Y si quitar los “frenos” del sistema inmunitario ayudara a combatir el #VIH?
🔬 En #IrsiCaixa demostramos, en el laboratorio, que combinar una #vacuna terapéutica con un #tratamiento anti PD-1 incrementa las células capaces de eliminar el VIH.
👉🏽 www.irsicaixa.es/es/el-efecto...
🔬 En #IrsiCaixa demostramos, en el laboratorio, que combinar una #vacuna terapéutica con un #tratamiento anti PD-1 incrementa las células capaces de eliminar el VIH.
👉🏽 www.irsicaixa.es/es/el-efecto...
🦠 Hoy, #DíaMundialMicrobioma, expertos se reúnen en
CosmoCaixa en la 11 edición del congreso #bcnmicrobiome, organizado por #IrsiCaixa.
🧠 Debaten terapias con bacterias, el papel de los metabolitos en la protección cerebral, entre otros temas.
👉🏽 irsicaixa.es/es/barcelona...
CosmoCaixa en la 11 edición del congreso #bcnmicrobiome, organizado por #IrsiCaixa.
🧠 Debaten terapias con bacterias, el papel de los metabolitos en la protección cerebral, entre otros temas.
👉🏽 irsicaixa.es/es/barcelona...
June 27, 2025 at 9:18 AM
🦠 Hoy, #DíaMundialMicrobioma, expertos se reúnen en
CosmoCaixa en la 11 edición del congreso #bcnmicrobiome, organizado por #IrsiCaixa.
🧠 Debaten terapias con bacterias, el papel de los metabolitos en la protección cerebral, entre otros temas.
👉🏽 irsicaixa.es/es/barcelona...
CosmoCaixa en la 11 edición del congreso #bcnmicrobiome, organizado por #IrsiCaixa.
🧠 Debaten terapias con bacterias, el papel de los metabolitos en la protección cerebral, entre otros temas.
👉🏽 irsicaixa.es/es/barcelona...
✈️ This week, IrsiCaixa took part in the #ISIDORe User Conference in Paris, an event on pandemic preparedness and response.
💉 We shared our research from the EU project @lwnvivat.bsky.social and joined roundtable discussions to help strengthen global responses to future health emergencies.
💉 We shared our research from the EU project @lwnvivat.bsky.social and joined roundtable discussions to help strengthen global responses to future health emergencies.
June 13, 2025 at 8:49 AM
✈️ This week, IrsiCaixa took part in the #ISIDORe User Conference in Paris, an event on pandemic preparedness and response.
💉 We shared our research from the EU project @lwnvivat.bsky.social and joined roundtable discussions to help strengthen global responses to future health emergencies.
💉 We shared our research from the EU project @lwnvivat.bsky.social and joined roundtable discussions to help strengthen global responses to future health emergencies.
🫱🏽🫲🏾 Gilead Sciences adquireix els actius d'investigació d'AELIX Therapeutics sobre la vacuna HTI contra el #VIH.
💉 Desenvolupada a partir d'un immunogen dissenyat inicialment a #IrsiCaixa, és un pas prometedor cap a noves estratègies en la lluita contra el VIH.
irsicaixa.es/ca/gilead-sc...
💉 Desenvolupada a partir d'un immunogen dissenyat inicialment a #IrsiCaixa, és un pas prometedor cap a noves estratègies en la lluita contra el VIH.
irsicaixa.es/ca/gilead-sc...
November 25, 2024 at 4:54 PM
🫱🏽🫲🏾 Gilead Sciences adquireix els actius d'investigació d'AELIX Therapeutics sobre la vacuna HTI contra el #VIH.
💉 Desenvolupada a partir d'un immunogen dissenyat inicialment a #IrsiCaixa, és un pas prometedor cap a noves estratègies en la lluita contra el VIH.
irsicaixa.es/ca/gilead-sc...
💉 Desenvolupada a partir d'un immunogen dissenyat inicialment a #IrsiCaixa, és un pas prometedor cap a noves estratègies en la lluita contra el VIH.
irsicaixa.es/ca/gilead-sc...
✈️ The #IrsiCaixa team lands at #CROI2025, the most important international conference on retroviruses.
🤝 We join renowned researchers from around the world to share knowledge, learn, and accelerate the search for solutions against #HIV and other viruses.
🤝 We join renowned researchers from around the world to share knowledge, learn, and accelerate the search for solutions against #HIV and other viruses.
March 12, 2025 at 8:20 AM
✈️ The #IrsiCaixa team lands at #CROI2025, the most important international conference on retroviruses.
🤝 We join renowned researchers from around the world to share knowledge, learn, and accelerate the search for solutions against #HIV and other viruses.
🤝 We join renowned researchers from around the world to share knowledge, learn, and accelerate the search for solutions against #HIV and other viruses.
🟣 #DiaMundialCàncerPàncrees.
🧬 Cada persona amb càncer de pàncrees té mutacions úniques que produeixen neoantígens. A #IrsiCaixa, investiguem quins neoantígens poden induir una resposta immunitària i servir per crear vacunes terapèutiques.
➕ informació: www.instagram.com/p/DCors8mIkt...
🧬 Cada persona amb càncer de pàncrees té mutacions úniques que produeixen neoantígens. A #IrsiCaixa, investiguem quins neoantígens poden induir una resposta immunitària i servir per crear vacunes terapèutiques.
➕ informació: www.instagram.com/p/DCors8mIkt...
November 21, 2024 at 2:47 PM
🟣 #DiaMundialCàncerPàncrees.
🧬 Cada persona amb càncer de pàncrees té mutacions úniques que produeixen neoantígens. A #IrsiCaixa, investiguem quins neoantígens poden induir una resposta immunitària i servir per crear vacunes terapèutiques.
➕ informació: www.instagram.com/p/DCors8mIkt...
🧬 Cada persona amb càncer de pàncrees té mutacions úniques que produeixen neoantígens. A #IrsiCaixa, investiguem quins neoantígens poden induir una resposta immunitària i servir per crear vacunes terapèutiques.
➕ informació: www.instagram.com/p/DCors8mIkt...
🔵 Join our team at #IrsiCaixa!
We’re #hiring for two new positions:
🔬 #Postdoc researcher
📊 Scientific research data manager
🫵🏽 If you’re passionate about advancing biomedical research, we’d love to hear from you!
➡️ irsicaixa.es/en/scientifi...
We’re #hiring for two new positions:
🔬 #Postdoc researcher
📊 Scientific research data manager
🫵🏽 If you’re passionate about advancing biomedical research, we’d love to hear from you!
➡️ irsicaixa.es/en/scientifi...
December 5, 2024 at 9:23 AM
🔵 Join our team at #IrsiCaixa!
We’re #hiring for two new positions:
🔬 #Postdoc researcher
📊 Scientific research data manager
🫵🏽 If you’re passionate about advancing biomedical research, we’d love to hear from you!
➡️ irsicaixa.es/en/scientifi...
We’re #hiring for two new positions:
🔬 #Postdoc researcher
📊 Scientific research data manager
🫵🏽 If you’re passionate about advancing biomedical research, we’d love to hear from you!
➡️ irsicaixa.es/en/scientifi...
www.elperiodico.cat/ca/societat/... #vih #hiv #aids #sida #cells #celulas #madre #trending #medicina #its #ets #ciencia #science #estigma #serofobia #curacion #viral #epidemia #avances #medicare #medical #sante #salut #sanitat #saude #sanidad #health #sanidade
Cura del VIH amb trasplantament de cèl·lules sense mutació
El ‘pacient de Ginebra’ és la primera persona al món que aconsegueix la remissió del VIH arran d’un trasplantament sense una mutació a les cèl·lules. IrsiCaixa ho qualifica d’«èxit sense precedents».
www.elperiodico.cat
March 19, 2025 at 4:15 PM
🎓 The doctor and researcher at #IrsiCaixa, @rutgerwalls.bsky.social, will be the new medical coordinator of the Medicine degree at the @upc.edu
⚕️ Paredes will help design an innovative curriculum that will integrate research and technology into medical education.
➡️ www.irsicaixa.es/en/principal...
⚕️ Paredes will help design an innovative curriculum that will integrate research and technology into medical education.
➡️ www.irsicaixa.es/en/principal...
April 2, 2025 at 8:02 AM
🎓 The doctor and researcher at #IrsiCaixa, @rutgerwalls.bsky.social, will be the new medical coordinator of the Medicine degree at the @upc.edu
⚕️ Paredes will help design an innovative curriculum that will integrate research and technology into medical education.
➡️ www.irsicaixa.es/en/principal...
⚕️ Paredes will help design an innovative curriculum that will integrate research and technology into medical education.
➡️ www.irsicaixa.es/en/principal...
🗣️ Today, Elisa Molina successfully defended her PhD thesis on targeting host protein translation for broad antiviral therapy.
👩🏽🎓 #IrsiCaixa welcomes a new doctor whose work strengthens our research community.
👏🏽 Congratulations, Dr Molina!
👩🏽🎓 #IrsiCaixa welcomes a new doctor whose work strengthens our research community.
👏🏽 Congratulations, Dr Molina!
November 17, 2025 at 3:51 PM
🗣️ Today, Elisa Molina successfully defended her PhD thesis on targeting host protein translation for broad antiviral therapy.
👩🏽🎓 #IrsiCaixa welcomes a new doctor whose work strengthens our research community.
👏🏽 Congratulations, Dr Molina!
👩🏽🎓 #IrsiCaixa welcomes a new doctor whose work strengthens our research community.
👏🏽 Congratulations, Dr Molina!
We're wrapping up the week with... 🥁
New PhD thesis defense! A huge congratulations to Irene, predoctoral researcher at IrsiCaixa 🎓
💙 Wishing you all the best in this new chapter, Dr González!
New PhD thesis defense! A huge congratulations to Irene, predoctoral researcher at IrsiCaixa 🎓
💙 Wishing you all the best in this new chapter, Dr González!
July 10, 2026 at 1:27 PM
We're wrapping up the week with... 🥁
New PhD thesis defense! A huge congratulations to Irene, predoctoral researcher at IrsiCaixa 🎓
💙 Wishing you all the best in this new chapter, Dr González!
New PhD thesis defense! A huge congratulations to Irene, predoctoral researcher at IrsiCaixa 🎓
💙 Wishing you all the best in this new chapter, Dr González!
🫱🏽🫲🏾 Gilead Sciences acquires AELIX Therapeutics investigational assets related to the HTI therapeutic #HIV vaccine.
💉 Developed from an immunogen initially designed at #IrsiCaixa, this marks a promising step toward innovative strategies in the fight against HIV.
irsicaixa.es/en/gilead-sc...
💉 Developed from an immunogen initially designed at #IrsiCaixa, this marks a promising step toward innovative strategies in the fight against HIV.
irsicaixa.es/en/gilead-sc...
November 25, 2024 at 4:52 PM
🫱🏽🫲🏾 Gilead Sciences acquires AELIX Therapeutics investigational assets related to the HTI therapeutic #HIV vaccine.
💉 Developed from an immunogen initially designed at #IrsiCaixa, this marks a promising step toward innovative strategies in the fight against HIV.
irsicaixa.es/en/gilead-sc...
💉 Developed from an immunogen initially designed at #IrsiCaixa, this marks a promising step toward innovative strategies in the fight against HIV.
irsicaixa.es/en/gilead-sc...
🌞 Ja estan en marxa els The Barcelona Debates on the Human Microbiome!
📍 Des del CosmoCaixa, experts internacionals compartiran, entre avui i demà, els darrers avenços en microbioma en aquest congrés de referència organitzat per IrsiCaixa.
📍 Des del CosmoCaixa, experts internacionals compartiran, entre avui i demà, els darrers avenços en microbioma en aquest congrés de referència organitzat per IrsiCaixa.
June 25, 2026 at 8:05 AM
🌞 Ja estan en marxa els The Barcelona Debates on the Human Microbiome!
📍 Des del CosmoCaixa, experts internacionals compartiran, entre avui i demà, els darrers avenços en microbioma en aquest congrés de referència organitzat per IrsiCaixa.
📍 Des del CosmoCaixa, experts internacionals compartiran, entre avui i demà, els darrers avenços en microbioma en aquest congrés de referència organitzat per IrsiCaixa.